https://doctransparency.com/doctor/tx/austin/ruy-carrasco-1063478154
Medicare Enrolled

Dr. Ruy Carrasco, MD

Pediatric Nephrology · Austin, TX
Mixed engagement
5301 DAVIS LN STE 200A, Austin, TX 78749
5124944000
In practice since 2006 (19 years)
NPI: 1063478154 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Carrasco from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Carrasco? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Carrasco

Dr. Ruy Carrasco is a pediatric nephrology in Austin, TX, with 19 years in practice.

Between the years covered by Open Payments, Dr. Carrasco received a total of $18,451 from 58 pharmaceutical and/or device companies across 371 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pediatric nephrology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Carrasco is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice$ $18,451 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$18,451
Total received (2018-2024)
Avg $2,636/year across 7 years
Top 7% in TX for pediatric nephrology
58
Companies
371
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,344 (45.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,445 (34.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$3,663 (19.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,558
2023
$1,673
2022
$7,103
2021
$5,202
2020
$1,453
2019
$492
2018
$972

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$6,791
PFIZER INC.
$3,091
Amgen Inc.
$1,464
MEDEXUS PHARMA, INC.
$880
ABBVIE INC.
$715
AbbVie Inc.
$566
GlaxoSmithKline, LLC.
$489
LivaNova USA, Inc.
$340
Mallinckrodt Hospital Products Inc.
$338
UCB, Inc.
$323
AbbVie, Inc.
$251
Horizon Therapeutics plc
$234
Genentech USA, Inc.
$213
Octapharma USA, Inc.
$207
E.R. Squibb & Sons, L.L.C.
$200
MEDAC PHARMA, INC.
$188
Ipsen Biopharmaceuticals, Inc
$152
JAZZ PHARMACEUTICALS INC.
$128
Neos Therapeutics, LP
$124
Kyowa Kirin, Inc.
$112
Zogenix Inc.
$106
Tris Pharma Inc
$93
Corium, LLC
$91
Ironshore Pharmaceuticals Inc.
$89
Neurelis, Inc.
$86
Antares Pharma, Inc.
$80
SK Life Science, Inc.
$76
Horizon Pharma plc
$74
UPSHER-SMITH LABORATORIES LLC
$64
Vertical Pharmaceuticals, LLC
$64
AQUESTIVE THERAPEUTICS, INC.
$61
Greenwich Biosciences, Inc.
$55
Mallinckrodt LLC
$47
ACADIA Pharmaceuticals Inc
$45
Upsher-Smith Laboratories LLC
$44
Janssen Biotech, Inc.
$44
Pharming Healthcare, Inc.
$43
Avion Pharmaceuticals
$35
Sandoz Inc.
$34
IRONSHORE PHARMACEUTICALS INC.
$33
Takeda Pharmaceuticals U.S.A., Inc.
$29
Kiniksa Pharmaceuticals, Ltd.
$29
Alexion Pharmaceuticals, Inc.
$29
Biocodex, Inc.
$26
TerSera Therapeutics LLC
$25
Otter Pharmaceuticals, LLC
$25
Supernus Pharmaceuticals, Inc.
$24
PTC Therapeutics, Inc.
$23
Novartis Gene Therapies, Inc. (fka AveXis, Inc.)
$21
Sobi, Inc
$20
Azurity Pharmaceuticals, Inc.
$19
Ultragenyx Pharmaceutical Inc.
$18
Lilly USA, LLC
$18
Aprecia Pharmaceuticals, LLC
$17
Biogen, Inc.
$16
Cumberland Pharmaceuticals, Inc.
$15
BioMarin Pharmaceutical Inc.
$15
Amneal Pharmaceuticals LLC
$14
Top 3 companies account for 61.5% of total payments
Associated products mentioned in payments ›
ACTHAR · AZSTARYS · Actemra · Adzenys XR-ODT · Arcalyst · Azstarys · BENLYSTA · Brineura · Briviact · COSENTYX · CRYSVITA · Cenobamate · Cotempla XR-ODT · Crysvita · DAYBUE · DIACOMIT · DYSPORT · Dyanavel XR · Dysport · EMFLAZA · EPIDIOLEX · Enbrel · Epidiolex · Fintepla · HUMATROPE · HUMIRA · HYRIMOZ · Humira · ILARIS · INFLECTRA · JORNAY PM · KRYSTEXXA · Methylphenidate Hydrochloride · Nayzilam · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ORENCIA · OTREXUP · Otrexup · PANZYGA · QUDEXY XR Topiramate Extended Release Capsules · Qelbree · Quzyttir · RAYOS · REDITREX · RELEXXII · RINVOQ · RUCONEST · RYLAZE · Rasuvo · Relexxii · Rituxan · SIMPONI · SKYRIZI · SPINRAZA · SYMPAZAN · Spritam · TAVNEOS · TREMFYA · Tavneos · VALTOCO · VIGADRONE · VIGADRONE (VIGABATRIN) FOR ORAL SOLUTION · VIMOVO · VNS - Sentiva · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VYVANSE · Vyvanse · XELJANZ · Xatmep · ZOLGENSMA · ZOMIG
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (45%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for pediatric nephrology in TX.

Looking for a pediatric nephrology in Austin?
Compare pediatric nephrologys in the Austin area by procedure volume, costs, and industry payment transparency.
Browse pediatric nephrologys nearby

Geographic Context

Pediatric Nephrologys within 10 mi
4
Per 100K population
0.3
County median income
$97,169
Nearest hospital
AUSTIN OAKS HOSPITAL
3.5 mi

Data Sources

Provider Registry✓ NPPESWeekly updates
Medicare Enrollment✓ PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments✓ Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Carrasco is a pediatric nephrology, and high industry engagement (mixed engagement, top 7%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Carrasco receive payments from pharmaceutical companies?
Yes. Dr. Carrasco received a total of $18,451 from 58 companies across 371 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Carrasco) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Pediatric Nephrologys in Austin
Browse pediatric nephrologys in Austin ranked by procedure volume and transparency data.
Highest volume
Top Pediatric Nephrologys in TX
Pediatric Nephrologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pediatric Nephrologys in TX
Which TX pediatric nephrologys receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc..
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →